Insider Selling: Envista (NYSE:NVST) SVP Sells $290,250.00 in Stock

Envista Holdings Corporation (NYSE:NVST) SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total transaction of $290,250.00. Following the transaction, the senior vice president directly owned 32,382 shares of the company’s stock, valued at $971,460. This represents a 23.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Envista Stock Up 0.7%

NVST stock opened at $28.99 on Friday. Envista Holdings Corporation has a twelve month low of $14.22 and a twelve month high of $30.42. The company has a quick ratio of 2.04, a current ratio of 2.38 and a debt-to-equity ratio of 0.47. The company has a market cap of $4.77 billion, a PE ratio of 103.52, a price-to-earnings-growth ratio of 1.97 and a beta of 1.01. The business’s 50-day simple moving average is $23.71 and its 200 day simple moving average is $21.54.

Envista (NYSE:NVST) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.32 by $0.06. Envista had a return on equity of 6.54% and a net margin of 1.73%.During the same period in the previous year, the business posted $0.24 earnings per share. The business’s revenue was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, research analysts anticipate that Envista Holdings Corporation will post 1 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Ariel Investments LLC grew its position in Envista by 1.7% during the 2nd quarter. Ariel Investments LLC now owns 12,355,666 shares of the company’s stock worth $241,430,000 after acquiring an additional 210,921 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Envista by 0.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 9,628,460 shares of the company’s stock worth $209,036,000 after purchasing an additional 90,586 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Envista by 16.7% during the second quarter. Franklin Resources Inc. now owns 8,956,572 shares of the company’s stock worth $175,011,000 after purchasing an additional 1,284,767 shares during the last quarter. Alliancebernstein L.P. grew its holdings in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock worth $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter. Finally, Clarkston Capital Partners LLC increased its stake in shares of Envista by 0.4% in the second quarter. Clarkston Capital Partners LLC now owns 4,703,330 shares of the company’s stock valued at $91,903,000 after buying an additional 16,583 shares in the last quarter.

Analyst Ratings Changes

A number of research firms have weighed in on NVST. Mizuho lifted their price target on shares of Envista from $24.00 to $27.00 and gave the stock a “neutral” rating in a research note on Tuesday. Morgan Stanley set a $19.00 target price on shares of Envista in a research report on Friday, February 6th. Weiss Ratings reissued a “sell (d)” rating on shares of Envista in a research note on Monday, December 29th. Evercore reissued an “outperform” rating and issued a $32.00 price target on shares of Envista in a research report on Friday, February 6th. Finally, Barclays lifted their price objective on Envista from $24.00 to $34.00 and gave the company an “overweight” rating in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, Envista currently has an average rating of “Moderate Buy” and a consensus target price of $27.43.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.